Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2023-09-19 Earnings Release
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Global Bioenergies : fortes avancées au premier semestre 2023
Earnings Release Classification · 100% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and details the company's financial results for the first half of 2023 ('fortes avancées au premier semestre 2023'). It presents key financial figures (revenue, net loss) and operational highlights (ASTM certification, production plans). This format, focusing on key results and commentary following the close of a reporting period (H1 2023), strongly indicates an Earnings Release (ER). It is not the comprehensive 'Interim Report' (IR) itself, but the initial announcement of the results, often released before the full statutory report is filed. The length (14,912 chars) is substantial but the content is structured as a summary announcement rather than a full statutory filing. H1 2023
2023-09-19 French
Global Bioenergies: strong progress in first half 2023
Earnings Release Classification · 99% confidence The document is explicitly titled 'PRESS RELEASE' and details the 'First half 2023 financial statements' approved by the Board of Directors on September 15, 2023. It includes key financial figures (revenue, net loss) for the six-month period ending June 30, 2023, along with a detailed Group Profit & Loss Account and Balance Sheet comparing H1 2023 to previous periods. This structure—a press release summarizing period-end financial results—is characteristic of an Earnings Release (ER). While it contains detailed financial tables, the format is that of an initial announcement rather than a comprehensive, formal regulatory filing like a 10-K or a full Interim Report (IR), which are typically filed with regulatory bodies. Given the focus on summarizing the 'first half' results immediately following the period end, 'ER' (Earnings Release) is the most appropriate classification. H1 2023
2023-09-19 English
Global Bioenergies revoit ses ambitions à la hausse
Regulatory Filings Classification · 98% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a strategic update regarding the company's industrial ambitions, specifically revising the planned capacity for a new plant and adjusting the roadmap. It mentions financial performance (H1 revenue) and future plans (publishing a construction timeline by year-end 2023). This type of announcement, which communicates significant business updates, strategic shifts, and sometimes preliminary financial highlights outside of a formal quarterly/annual report, is best classified as an Earnings Release (ER) if it contains results, or a general Regulatory Filing (RNS) if it's purely strategic. Since it contains a brief financial update (H1 revenue) and is a formal press release announcing a major operational/strategic change, it aligns closely with the function of an Earnings Release (ER) which often precedes or accompanies the full report, or a general announcement. Given the focus on strategic revision and operational updates rather than just pure financial figures, and considering the short length (under 5,000 characters) and format (Press Release), it functions as an immediate public disclosure. While it's not a formal quarterly report (IR) or annual report (10-K), the content strongly suggests a significant business update. In many databases, strategic press releases containing key operational and financial highlights are categorized under ER or RNS. Since it's a formal press release announcing strategic direction and mentioning recent revenue, ER is a strong candidate, but RNS serves as the best general regulatory announcement fallback for non-standard disclosures. However, because it explicitly mentions H1 revenue (€2.4 million) and discusses future plans following recent performance, it functions similarly to an Earnings Release (ER) announcing results and outlook, even if it's not the full detailed report. Given the options, ER captures the essence of reporting recent performance alongside strategic outlook better than RNS, which is a fallback. I will classify it as ER based on the inclusion of recent financial figures and forward-looking statements in a press release format.
2023-07-27 French
Global Bioenergies raises its ambitions
Earnings Release Classification · 95% confidence The document is titled 'PRESS RELEASE' and announces a strategic shift: 'Global Bioenergies raises its ambitions' regarding plant sizing and production focus. It details changes to the industrial roadmap, production targets, and market focus (cosmetics, sustainable aviation fuels). This type of announcement, detailing strategic operational changes, financial performance highlights (€2.4 million first-half revenue), and future plans, is characteristic of an Earnings Release (ER) or a general strategic update. Since it is a press release announcing results and strategic direction rather than a full, comprehensive report (like 10-K or IR), 'ER' (Earnings Release) is the most appropriate classification for the initial announcement of key financial and operational news. The document length (4171 chars) is consistent with a press release format. H1 2023
2023-07-27 English
Bilan semestriel du contrat de liquidité au 30/06/2023
Regulatory Filings Classification · 99% confidence The document is a 'COMMUNIQUE DE PRESSE' (Press Release) dated July 21, 2023, providing the 'Bilan semestriel du contrat de liquidité au 30/06/2023' (Semi-annual statement of the liquidity contract as of 06/30/2023). This document details the activity (purchases and sales of shares) under a liquidity agreement managed by a broker (Gilbert Dupont) up to the mid-year point. This type of announcement, which reports on specific financial arrangements or transactions related to the company's own shares (in this case, liquidity management), fits best under the category related to share transactions or capital structure changes. Since it specifically details transactions in the company's own shares under a liquidity contract, it aligns closely with 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), an interim report (IR), or a formal regulatory filing like a 10-K. Given the focus on share transactions for market stability, POS is the most precise fit.
2023-07-21 French
Global Bioenergies: Global Bioenergies' SAF technology receives ASTM certification
Regulatory Filings Classification · 95% confidence The document is a press release dated June 20, 2023, announcing that Global Bioenergies' Sustainable Aviation Fuel (SAF) technology has received ASTM certification. It details the significance of this certification for blending with fossil kerosene and mentions upcoming publication of the updated ASTM D7566 standard. It also includes quotes from the CEO and a partner, and announces a press conference. This type of announcement, which communicates a significant, specific, non-periodic corporate event or achievement (like a major certification or regulatory milestone) via a press release format, does not fit neatly into the defined financial filing categories (10-K, IR, ER, etc.). It is a general corporate announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback category for general, non-standard regulatory or significant corporate news releases that aren't explicitly about earnings, dividends, or management changes.
2023-06-20 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.